The considerable mortality and morbidity associated with atrial fibrillation (AF) pose a
substantial burden on patients and health care services. Although the management of AF …

Atrial fibrillation (AF), the most common sustained arrhythmia observed in clinical practice, is
a chronic and progressive disorder characterized by exacerbations and remissions …

Background: In patients with heart failure and atrial fibrillation (AF), several clinical trials
have reported improved outcomes, including freedom from AF recurrence, quality of life, and …

Importance Early rhythm control of atrial fibrillation (AF) with either antiarrhythmic drugs
(AADs) or catheter ablation has been reported to improve cardiovascular outcomes …

Background: Observational data suggest that catheter ablation may be safe and effective to
treat younger and older patients with atrial fibrillation. No large, randomized trial has …

Background: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for
Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point of …

Background: Among patients with atrial fibrillation (AF), women are less likely to receive
catheter ablation and may have more complications and less durable results. Most …

Background: Whether the amount of atrial fibrillation (AF) patients experience conveys
important prognostic information beyond that provided by the diagnosis of AF is uncertain …

In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based
safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007 …

In contrast to current guidelines and earlier trials, recent studies demonstrated superiority of
rhythm-over rate-control and challenged the strategy of" rate versus rhythm" therapy in …